JUN 27, 2019 10:50 AM PDT

Remote Controlled Drug Delivery?

WRITTEN BY: Nouran Amin

According to the CDC, chronic diseases although the most common are preventable of all medical problems. Chronic diseases ranging from arthritis to heart disease and diabetes leave its patients with the inconveniences of the daily regimen of pills and scheduled medication dosage. Now, researchers from Houston Methodist have aimed to solve this problem by implanting a battery-powered grape-sized implant that is remotely controlled and made with similar technology used in the silicon semiconductor industry.

Using a nanochannel delivery system (nDS) controlled via Bluetooth technology, two dosages of drug delivery were successfully demonstrated without the need for pumps, valves, or a power supply and researchers are now planning to test in space.

"We see this universal drug implant as part of the future of health care innovation. Some chronic disease drugs have the greatest benefit of delivery during overnight hours when it's inconvenient for patients to take oral medication. This device could vastly improve their disease management and prevent them from missing doses, simply with a medical professional overseeing their treatment remotely," said Alessandro Grattoni, Ph.D., corresponding author and chair of the department of nanomedicine at Houston Methodist Research Institute.

The proof-of-concept paper was published in Lab on a Chip and describes how the device is implanted under the skin and utilizes a nanofluidic membrane that can deliver drugs tailored to each patient with correct dosage and schedule. The implant, which contains a microchip that is Bluetooth enabled and relies on wireless communication, can deliver drugs up to a year before a refill is needed. The microchip essentially is programmed for different drug release settings -- standard, decreased and increased.

Researchers are hopeful that their study may someday be the building ground for advancing telemedicine and helping clinicians treat their patients better.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 18, 2019
Drug Discovery
JUL 18, 2019
Chemopreventative Drug Targets H. Pylori Infections
A chemopreventative drug being tested for its ability to inhibit the production of cell growth in multiple types of cancer was found to act directly on the...
JUL 18, 2019
Drug Discovery
JUL 18, 2019
The Microfluidic-Based Drug Screening Chip
A team of researchers, at the Korea Advanced Institute of Science and Technology (KAIST), created a high throughput microfluidic-based drug screening chip ...
JUL 18, 2019
Drug Discovery
JUL 18, 2019
Drug Regimen Improves Clinical Outcomes for Kidney Transplant Patients
Recent preliminary clinical trial results indicate the immunosuppressive drug belatacept can safely and effectively treat kidney transplant patients withou...
JUL 18, 2019
Drug Discovery
JUL 18, 2019
Injectable Hydrogel Recruits Chemotherapeutics to Tumor Site
Targeting tumor cells while avoiding harming healthy tissue remains a growing central challenge in the field of chemotherapeutics. For a while, scientists ...
JUL 18, 2019
Drug Discovery
JUL 18, 2019
Breakthrough Synthesis Advances Potent Anti-Cancer Agent
What is now known as a "landmark in drug discovery", Harvard chemists have succeeded in synthesizing halichondrin, found naturally in sea sponges...
JUL 18, 2019
Drug Discovery
JUL 18, 2019
'Sugar-coating' proteins to treat pancreatitis?
A powerful biomarker created by complex sugar molecules, called CA19-9, may be a target for the treatment of pancreatitis. Pancreatitis is an inflammatory ...
Loading Comments...